Vera Therapeutics is trading at $30.00, down 7.81% in pre-market on September 28, 2026, versus the September 25 close of $32.54, amid broader risk-off conditions; no direct link to the move is established. - Nasdaq futures were down 0.84% in the supplied market context, alongside renewed oil and yield concerns. - No September 28 company announcement appears in Vera Therapeutics’ press-release listing; its latest listed release, dated September 15, covers positive ORIGIN 3 results.